[1] |
JIANG Daoli, CHOU Xiaohua, LIU Zhidong, LI Wei, ZHANG Bo, XU Sang, TAN Defei, FANG Yi, LV Dongmei, WANG Tao.
Real-world study of ceftazidime-avibactam in the treatment of multidrug-resistant gram-negative bacterial infections
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1008-1017.
|
[2] |
WU Yujie, ZHAO Chengcheng, XI Qing.
Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033.
|
[3] |
MA Xiankang, YANG Lixia, CUI Yangyang, MI Denghai.
Angelica polysaccharides improve hepatic endoplasmic reticulum stress by inhibiting the expression of GRP78, p-PERK and p-Eif2α in diabetic KK-Ay mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 926-936.
|
[4] |
HAO Xiao, ZHAO Mei, WANG Wenjing, ZHANG Feifei, LIU Huiliang, DANG Yi, LI Shuren, QI Xiaoyong.
Application of sodium-glucose cotransporter 2 inhibitors in acute myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 824-831.
|
[5] |
QIAO Hongliang, DING Ning, DENG Kaihong, LIU Binbin, DONG Chuanjiang, CHEN Xiaobo, ZOU Lili.
New progress in research on novel control strategies for methicillin-resistant staphylococcus aureus infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 676-687.
|
[6] |
DANG Zilong, LIU Haiyang, ZHANG Yangfan, LIU Jinfeng, ZHANG Tianwei, LI Bin, GUO Hong, CHENG Wenyuan, XU Xiaohui, LI Yile, WEI Yuhui, WU Xin'an.
Optimization strategy of antibiotic dosing regimen in intensive care unit patients with augmented renal clearance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 561-571.
|
[7] |
ZHANG Huabin, LUO Zhongxu, ZHONG Min, HONG Zongyuan, WANG Deguo.
Study on the effect of spinal anesthesia on ventricular arrhythmias in acute myocardial ischemia-reperfusion in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 249-256.
|
[8] |
LI Shan, LIU Yixin, REN Feifei, LI Xiangchen, ZHANG Zhiqing.
Research progress of natural plant active ingredients in reversing tumor multidrug resistance by down-regulating P-gp
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 331-340.
|
[9] |
YU Yahong, SONG Yu.
Pharmacotherapy of patients with left ventricular assist devices
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 198-204.
|
[10] |
LIU Jiajia, GAO Yan, ZHANG Yehui, WU Jing.
Functions of CRABP2 in tumorigenesis and progression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 86-92.
|
[11] |
DONG Wei, HUANG Xiaoying, XIE Bingbin, TANG Xilan, LI Hongming, QIU Yumei, ZHAO Guowei, LIANG Xinli.
Effects of oxypeucedanin on the resistance of breast cancer MCF-7/DOX cells to doxorubicin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 260-266.
|
[12] |
XU Hui, YANG Xinyu, ZHAO Zhehui, WANG Yan.
Research progress and thinking on the metabolism of polysaccharide drugs in vivo and the key technology of PK/PD
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 851-862.
|
[13] |
MENG Qiang, LIU Kexin.
Research status and prospect of transporter-mediated drug-drug interactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 876-888.
|
[14] |
FU Xiangjun, HUANG Li, GUO Li, LIN Liangmo.
Application of AUC/MIC as the therapeutic drug monitoring target of vancomycin in patients with severe infections of multi drug resistant gram positive bacteria
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 775-781.
|
[15] |
YANG Hechun, SHI Daohua .
Research progress of small molecule inhibitors that reverse tumor drug resistance by regulating tumor glucose metabolism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 836-840.
|